2022 - Research.com Microbiology in Australia Leader Award
2020 - Fellow of the Australian Academy of Health and Medical Science
Roy M. Robins-Browne mainly focuses on Microbiology, Virulence, Escherichia coli, Virology and Immunology. He has researched Microbiology in several fields, including Plasmid, Yersinia enterocolitica, Secretion, Enterobacteriaceae and Diarrhea. Roy M. Robins-Browne is investigating Virulence as part of his inquiry into Genetics and Gene.
His Escherichia coli study combines topics in areas such as Small intestine and Cecum. His biological study spans a wide range of topics, including Fimbria, Bacterial adhesin and Shiga toxin. His Immunology research is multidisciplinary, relying on both Probiotic, Cystic fibrosis and Pseudomonas aeruginosa.
Roy M. Robins-Browne mainly investigates Microbiology, Virulence, Escherichia coli, Immunology and Enterobacteriaceae. His research in Microbiology intersects with topics in Plasmid, Yersinia enterocolitica, Bacteria, Virology and Enteropathogenic Escherichia coli. Roy M. Robins-Browne has included themes like Citrobacter rodentium and Regulation of gene expression in his Virulence study.
Roy M. Robins-Browne combines subjects such as Molecular biology and Diarrhea with his study of Escherichia coli. His study in Immunology is interdisciplinary in nature, drawing from both Internal medicine, Streptococcus pneumoniae and Tuberculosis. His studies deal with areas such as Pathogen and Intestinal mucosa as well as Enterobacteriaceae.
His scientific interests lie mostly in Microbiology, Immunology, Genetics, Virulence and Streptococcus pneumoniae. His study of Pathogen is a part of Microbiology. The various areas that Roy M. Robins-Browne examines in his Immunology study include Disease and Tuberculosis.
The study incorporates disciplines such as Enterotoxin and Intimin in addition to Virulence. His Streptococcus pneumoniae study combines topics from a wide range of disciplines, such as Meningitis, Probiotic bacterium and Haemophilus influenzae. His research on Escherichia coli also deals with topics like
His primary areas of study are Immunology, Microbiology, Escherichia coli, Enteropathogenic Escherichia coli and Diarrhea. His work on Allergy, Immune system, Gut flora and BCG vaccine as part of general Immunology study is frequently connected to Terminal restriction fragment length polymorphism, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His Vaccination research extends to the thematically linked field of Microbiology.
His Escherichia coli study incorporates themes from Transport protein and Genome. His Enteropathogenic Escherichia coli study is related to the wider topic of Virulence. His Diarrhea study also includes fields such as
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study.
Karen L. Kotloff;James P. Nataro;William C. Blackwelder;Dilruba Nasrin.
The Lancet (2013)
Probiotic use in clinical practice: what are the risks?
Robert J Boyle;Roy M Robins-Browne;Mimi L K Tang.
The American Journal of Clinical Nutrition (2006)
Emergence of multiply resistant pneumococci.
M R Jacobs;H J Koornhof;R M Robins-Browne;C M Stevenson.
The New England Journal of Medicine (1978)
Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells.
James P. Nataro;James B. Kaper;Roy Robins-Browne;Valeria Prado.
Pediatric Infectious Disease Journal (1987)
Characterization of Enteroadherent-Aggregative Escherichia coli, a Putative Agent of Diarrheal Disease
Pablo A. Vial;Roy Robins-Browne;Hermy Lior;Valeria Prado.
The Journal of Infectious Diseases (1988)
Chips with everything: DNA microarrays in infectious diseases
Penelope A Bryant;Deon Venter;Roy Robins-Browne;Nigel Curtis.
Lancet Infectious Diseases (2004)
Effects of iron and desferrioxamine on infections with Yersinia enterocolitica.
R M Robins-Browne;J K Prpic.
Infection and Immunity (1985)
Identification of a novel genetic locus that is required for in vitro adhesion of a clinical isolate of enterohaemorrhagic Escherichia coli to epithelial cells
Larissa Nicholls;Travis H. Grant;Roy M. Robins-Browne.
Molecular Microbiology (2000)
Traditional Enteropathogenic Escherichia coli of Infantile Diarrhea
Roy M. Robins-Browne.
Clinical Infectious Diseases (1987)
Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR.
Benjamin P Howden;Christopher R E McEvoy;David L Allen;Kyra Y L Chua;Kyra Y L Chua.
PLOS Pathogens (2011)
(Impact Factor: 5.335)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: